Valeria Caso, is a stroke neurologist at the University of Perugia Stroke Unit, Italy and certified full professor in Neurology. She is former president of the European Stroke Organisation (ESO). She has authored and co-authored more than 300 published papers and book-chapters. She has been involved in 20 multicentre trials serving in various positions including steering committees. She is currently actively involved in international research projects on heart and brain, intracerebral haemorrhage, and acute stroke treatment. She has made primary interest the treatment and prevention of stroke in women.

I am a Professor of Clinical Neurology in the Department of Clinical and Movement Neuroscience at the Institute of Neurology, UCL, Queen Square, London and an Honorary Consultant Neurologist at the affiliated National Hospital for Neurology, Queen Square. I obtained my medical degree and also neurology degree from Bombay University India and obtained further training in neurogenetics and movement disorders with the late Professor’s Anita Harding and David Marsden at Queen Square London. I am a Fellow of the Royal College of Physicians and corresponding Fellow of the American Academy of Neurology.

My main research interest is in movement disorders, merging clinical, electrophysiological, and genetic methods to study the pathophysiology of movement disorders conditions like Dystonia, Parkinson’s disease and atypical parkinsonian syndromes. I currently have over 620 peer reviewed publications, several book chapters and have edited 4 books including a large reference tome “Marsden’s book of Movement Disorders” by Oxford University Press (OUP) which was the recipient of the best book in Neuroscience award at the BMA awards in 2013. I am the current and founding editor in chief of Movement Disorders Clinical Practise Journal (MDCP) and have previously been the Associate Editor of Movement Disorders Journal (MDJ).

I have served on several International committees of the MDS and the ENS, EFNS including the International Executive Committee (IEC) of Parkinson’s disease and Movement Disorders Society and their central science program committee (CSPC). I am on the executive committee for movement disorders for the Association of British Neurology (ABN). I have been an active member of the EAN as a delegate and full individual member and was the subcommittee chairman of movement disorders when the EAN was formed. I start a term in 2019 for two years as Secretary- elect of the MDS- ES to continue the close collaboration in the education programs with the EAN and other bodies.

Dr. Abdulrazaq Albilali is a highly accomplished medical professional with a diverse background. He completed his undergraduate certificate at King Saud University in 2009 and earned a Master's degree in Experimental Medicine (MSc) from the same university in 2014

In 2017, he completed his residency training in Neurology at the University of British Columbia, followed by a fellowship in Headache Medicine at the university's multidisciplinary headache clinic in 2019. Dr. Albilali also holds a Master's degree in Health Administration (MHA) from the University of British Columbia, obtained in 2019. He has held prestigious positions as the head of the Neurology unit at King Saud University Medical City and College of Medicine (2021-2023) and as the head of the Saudi Headache Chapter (2020-present).

Dr. Bashar Katirji is the Director of the Neuromuscular Center and Electromyography (EMG) laboratory at University Hospitals Cleveland Medical Center and Professor of Neurology and at Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. He also served as the Director of the Neuromuscular fellowship training program from 1991 till 2021.

Dr. Katirji has published extensively is continually active in teaching and clinical research in the field of Neuromuscular Medicine and Electrodiagnostic Medicine. He has authored more than 100 articles in peer-reviewed journals and more than 50 chapters in neurologic textbooks.

Dr. Katirji has authored an EMG textbook, Electromyography in Clinical Practice, now in its third edition and co-authored the textbook, Neuromuscular Disorders in Clinical Practice, a widely utilized reference text in the US and abroad, now in its second edition. Dr. Katirji also co-authored a Nerve Conduction Study manual for trainees and technologists, a book on Stiff Person Syndromes and Related Disorders and a recent Neuromuscular and Electrodiagnostic Medicine Board Review book. He has directed and lectured in numerous continuing medical education courses on neuromuscular disorders and electrodiagnostic testing at the American Academy of Neurology and the American Association of Electrodiagnostic Medicine annual meetings, as well as many other international associations' seminars. He is a reviewer for many U.S. and international neurologic peer-reviewed journals.

He is a fellow of the American Neurological Association, American College of Physicians, and American Academy of Neurology. He has received many awards including the Distinguished Physicians Award, the Robert B. Daroff teaching Award and the Dennis M. Landis teaching Award. He has been voted one of the TOP DOCTORS in America yearly from 1994 through 2023.

Messoud Ashina, MD, is a professor of neurology in the faculty of health and medical sciences, University of Copenhagen, Denmark. Professor Ashina received his Doctor of Medicine degree at the Azerbaijan Medical University. He completed his residency in neurology at the University of Copenhagen. Dr. Ashina received his PhD and DMSc degrees at the University of Copenhagen.

He is director of the Human Migraine Research Unit at the Danish Headache Center and Department of Neurology, Rigshospitalet Glostrup.

Professor Ashina has been actively involved in headache research since 1995. His research interests include experimental migraine and cluster headache models, neuroimaging, novel antimigraine drug targets, the mechanism of migraine, and the action of antimigraine medications. He has authored over 400 papers, abstracts, and book chapters on the topic of headache, including migraine and cluster headache.

Professor Ashina serves as associate editor of three journals: Cephalalgia, Brain, and The Journal of Headache and Pain. He is also immediate past president of the International Headache Society.

Dr. Adel Al-Hazzani has been working as an associate professor at King Saud University’s College of Medicine in Riyadh since January 2019.

Al-Hazzani has a long academic career teaching at different medical colleges across Saudi Arabia. He graduated from King Khaled University (KKU) in Abha in 2001 with a bachelor’s degree in medicine. Al-Hazzani proceeded to Canada to complete a neurology residency program at McGill University in Montreal.

He spent the years between 2008 and 2010 at Harvard University in Massachusetts, US, doing a medicine fellowship in vascular neurology and interventional neuroradiology.

Al-Hazzani has been teaching neurology at KKU since 2017. He also served as the chairman of KKU’s clinical biochemistry department and vice dean of clinical affairs at the Medicine College, and dean of the Pharmacy College during this stint with KKU.

Al-Hazzani served as a consultant at the King Abdul Aziz Medical City from June 2016 to September 2017.

Thomas Berger, MD, MSc, FEAN, is Professor of Neurology and Chair of the Dept. of Neurology as well as Chair of the Comprehensive Center for Clinical Neurosciences & Mental Health at the Medical University of Vienna, Austria. He graduated in 1991 and postgraduated in 2002 in “Hospital Management and Health Economics “. His career started 1992 at the Dept. of Experimental Neuropathology and Neuroimmunology (Hans Lassmann), followed by residency at the Dept. of Neurology, Univ. of Vienna, from 1993-1995. In 1995 he moved to the Dep. of Neurology, Medical Univ. of Innsbruck, to continue his academic track (1998 board certification in neurology and psychiatry, habilitation in 2003 and Vice-Director of the Dept. of Neurology from 2014-2018). Scientific interests regard neuroimmunology, with specific focus on inflammatory demyelinating CNS disorders. He has published about 400 peer-reviewed papers/research letters/invited reviews and several books/book chapters.

He was awarded several times, including by ECTRIMS and the European Charcot Foundation and was/is principal investigator in more than 70 clinical treatment trials. T. Berger is currently past-president of the Austrian Society of Neurology, serves as National Multiple Sclerosis Coordinator of the Austrian Society of Neurology and is member/chair of numerous international and national multiple sclerosis organizations and panels. Recently he was also appointed as member of the Austrian Supreme Public Health Council. T. Berger is actively engaged in the European Academy of Neurology as Board Member, Chair of the Scientific Committee, Chair of the Task Force “Teleneurology” and Member of the Task Force “General Neurology”.

Patricia Pozo-Rosich MD PhD, is a specialist in Neurology. She is Head of Section of the Neurology Department and Director of the Migraine Adaptive Brain Center at the Vall d’Hebron University Hospital in Barcelona. She is the Principal Investigator of the Headache Research Laboratory at the Vall d’Hebron Institute of Research (VHIR), which belongs to the Universitat Autonoma of Barcelona(UAB).

She is the Honorary Secretary of the Executive Board of the International Headache Society, and past member of the European Headache Federation Council, past Coordinator of the Spanish Headache Study Group of the Spanish Neurological Society (cefaleas.sen.es).

Dr. Abdullah Al Salti Graduated from Sultan Qaboos University, College of Medicine, B.Sc (Bachelor in Basic health Sciences), acquiring MD in 2002, is a member of Royal College of Physician MRCP UK since 2006. Along with Neurology residency program at McGill University 2008-2013 to his credit, he has acquired FRCPC neurology in 2013 Completing his Fellowship in Neuromuscular & EMG at McGill university June 2014.

• Member of American Academy of neurology (AAN 2010)
• At present working as Consultant neurologist, neuromuscular & EMG specialist.
• Head of Neurology Department at Neuroscience, Khoula Hospital, Muscat.
• President of Oman Neurological Society (ONS)
• Member of the Scientific Education Committee, Internal Medicine Program, at Oman Medical Specialty Board (OMSB).
• Senior Clinical Lecturer, College of Medicine & Health Sciences, Sultan Qaboos University.

Dr. Abubaker Almadani completed his undergraduate certificate in 1997 from the University of Gothenburg, Sweden. In Gothernburg University, he was involved in teaching and contributed in research study with Dr. Anders Hamberger in neuroprotective agents in acute stroke. Then, he completed his Canadian Royal College in Neurology (FRCPC) in 2009.

Dr. Madani had his residency at the University of Toronto which is ranked number 1 in Canada by Royal College of Canada, and ranked number 4 in the whole North America by American Academy of Neurology. He was personally involved in regional stroke program and he was involved in at least 500 stroke cases and 80 TPA cases. In his residency he also did one whole elective year which involves EEG, research, pathology and nerve conduction studies. By finishing the residency, he was able to manage neurological cases as general neurological cases as general neurologist in 2007. He has his fellowship in neuromuscular subspecialty from 2007 to 2009.

• Deputy Director, Neuroscience Center
• Director, Movement Disorders Fellowship Program
• Director, Movement Disorders IPU, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

Raed Alroughani received a degree in medicine from Charles University. He finished his neurology residency from the University of British Columbia and obtained the neurology certification from the Royal College of Physicians & Surgeon (Canada). He then finished a fellowship in demyelinating disorders at the University of British Columbia. He worked as attending neurologist at the Royal Columbian Hospital (Canada), after which he joined the division of neurology at Amiri hospital (Kuwait). He established the first multi-disciplinary MS clinic at Dasman Research Institute in 2011. He currently serves as a director of MS clinic in Dasman Research institute and as a head of MS clinic at Ibn-Sina hospital.

Dr. Alroughani’s fields of interest are principally directed towards the epidemiology and therapeutics of multiple sclerosis. He established the first national MS registry in Kuwait. He currently serves in the scientific leadership group of MS Base, which represents the largest international MS database involving more than 60 countries. He published many key papers on the natural history of MS and use of disease modifying therapies in Kuwait.

Dr. Alroughani served as a member of the joint ethical committee formed by Kuwait University and Ministry of Health. He is the past treasurer of the Kuwait Neurological Society. He currently sits on the executive boards of various scientific associations, steering committees and advisory boards, mainly in the field of MS.

• Dr. Fatema is a Chairperson of Clinical Neuroscience Department at Salmaniya Medical Complex
• Chairperson of Bahrain Neuroscience Association, and a member in the ILAE EMR board.
• Various neurological disorders like headache, Epilepsy, stroke, dementia, Parkinson’s disease and other movement disorders, Multiple Sclerosis and peripheral neuropathy
• BOTOX injection for migraine, spasticity and other movement disorders
• Reporting Nerve conduction studies and EEG.

• Stroke neurologist at Jaber hospital and head of stroke unit
• SITS national coordinator
• Member of MENASO Education Committee, MENASO Women & Stroke Committee in addition to the MENASO Stroke Advisory Board.
• Clinical tutor and assistant program director of adult neurology, KIMS

Dr. Namareq Aljarki is a Specialist Neurologist, and the director of MS clinic at Mubarak Hospital. She received her degree in medicine (MD) from Kuwait University. She completed her Neurology Residency at the Kuwaiti board of neurolgy. She then completed a fellowship in Multiple Sclerosis at the University of Toronto (Canada).

Dr. Lamya Alsarraf is a Neuroradiologist and head of medical imaging department in a specialized hospital seeking to develop a network of professionals to advance the medical field in Kuwait.

Dr. Michael Geschwind is a Professor of Neurology at the University of California, San Francisco, where he does clinical research on rapidly progressive dementias, including prion disease, as well as Huntington’s Disease, Spinocerebellar Ataxia, and atypical Parkinsonian disorders.

He began his medical career at the Albert Einstein College of Medicine where he received his M.D. and Ph.D. in neuroscience. He completed his internal medicine internship at UCLA, neurology residency at the Johns Hopkins School of Medicine and fellowship in neurobehavior at the University of California, San Francisco (UCSF) Medical Center, Memory and Aging Center, where he stayed on as faculty.

The majority of his research effort at UCSF has been in the evaluation and treatment of rapidly progressive dementias, particularly human prion diseases, such as Jakob-Creutzfeldt Disease (JCD). At UCSF, he developed the first ever program in the United States for the evaluation of rapidly progressive dementias. Over the past 15 years, he has helped recruit the largest clinical cohort of patients with potential prion disease in the United States, as well as patients with other non-prion rapidly progressive dementias.

As part of an NIH grant with Dr. Stanley Prusiner, Drs. Geschwind and Bruce Miller completed the first ever treatment trial for sJCD in the United States. Although the results of this trial did not show that the drug quinacrine prolonged survival, the data collected on the course of JCD will be invaluable for future treatment trials. At UCSF, Dr. Geschwind supervises a clinical and research team studying and treating prion diseases; they evaluate patients from all over the U.S. as well as from other countries. In his research efforts, he has realized that unless diagnosis is made earlier, any potential treatment might be too late. Towards this goal Dr. Geschwind has received NIH grants to identify specific clinical, laboratory and imaging findings that will allow for earlier diagnosis of human prion disease. He was a member of, and now consults for, the U.S. Food and Drug Administration (FDA) Advisory Panel on Transmissible Spongiform Encephalopathies (TSEs). In 2013, Dr. Geschwind joined the National Organization for Rare Disorders (NORD) Research Hall of Fame for his work on prion disorders and other rare dementias.

Dr. Geschwind also is involved clinically in caring for patients with Alzheimer’s disease, frontotemporal dementia, Huntington’s disease, CADASIL, atypical Parkinsonian dementias and various neurogenetic disorders. Dr. Geschwind’s research efforts also have been supported by the John Douglas French Foundation for Alzheimer’s Research, the McBean Family Foundation, the Homer Family Fund, the Tau Consortium and CurePSP.

Dr. Mohammad Ashkanani is a graduate of the Royal College of Surgeons in Ireland (RCSI) 2007. He did his internship at Beaumont Hospital, Dublin 2008. Dr. Ashkanani completed his neurology residency and epilepsy fellowship from the University of British Columbia (UBC) 2016. Since then, he is a fellow of the Canadian Royal College of Physicians and is working as a neurologist and epileptologist at Amiri Hospital neurology department in Kuwait.

• Consultant Neuroradiologist
• Neuroradiology Fellowship, Johns Hopkins University
• Research Fellowship, Virginia Tech Neuroimaging Lab
• Advanced Neuroimaging Masters, University College London
• Health Professions Education Masters, Maastricht University

• Neurology specialist, Farwaniya hospital
• Kuwait Neurology Board 2017
• MRCP SCE, neurology 2018
• Neuromuscular specialization, UK 2021
• Neurology program assistant director, 2018-2020
• Site coordinator for neurology program at Farwaniya hospital 2017-until now
• Tutor at neurology and internal medicine residency programs

• Professor of Ophthalmology
• Weill Cornell Medical College
• Chairman, Department of Ophthalmology, The Methodist Hospital, Houston, TX
• Adjunct Professor of Ophthalmology, Baylor College of Medicine
• Adjunct Professor of Ophthalmology, University of Iowa Hospitals and Clinics
• Clinical Professor of Ophthalmology, Department of Ophthalmology and Visual Sciences, University of Texas Medical Branch at Galveston

Andrew G. Lee, M.D. is chair of the Department of Ophthalmology at The Methodist Hospital in Houston, Texas and is Professor of Ophthalmology, Neurology, and Neurosurgery at Weill Cornell Medical College. He is adjunct professor of Ophthalmology at Baylor College of Medicine and the University of Iowa and Clinical Professor at the University of Texas Medical Branch in Galveston, Texas. Dr Lee serves on the national and international Editorial Board of 12 journals including the American Journal of Ophthalmology, the Canadian Journal of Ophthalmology, the Japanese Journal of Ophthalmology, the Journal of Neuro-ophthalmology, and Eye and is the editor in chief of the Journal of Academic Ophthalmology. He has published over 300 peer-reviewed articles, 40 book chapters, and eight full textbooks in ophthalmology. He has been the invited speaker at over 35o national and international eye meetings and has delivered 12 named lectures. He has a special interest in resident education and enjoys teaching about teaching in ophthalmology.

Education:

• 1974-1978 Harvard College B.A. Cambridge, Massachusetts
• 1979-1981 Harvard College Premedical Cambridge, Massachusetts Studies
• 1981-1985 Oregon Health Sciences University M.D. Portland, Oregon

Postgraduate Training:

• 1985-1986 Medical Intern Yale Dept Psychiatry, Greenwich Hospital Greenwich, Connecticut
• 1986-1989 Neurology Residency Johns Hopkins Hospital Baltimore, Maryland
• 1989-1991 Epilepsy and Electrophysiology Fellowship Johns Hopkins Hospital Baltimore, Maryland

Experience:

• 1991-1993 Instructor, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland
• 1993-2002 Assistant Professor, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland
• 1996-present Director, Adult Epilepsy Clinic, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland
• 2003-2009 Associate Professor, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland
• 2009-Present Professor, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland